This study examined changes in bone metabolism markers in patients with T2DM and DKD, focusing on the association of klotho, FGF23, 25(OH)D3, iPTH, Ca and PHOS levels with the severity of DKD. Here, FGF23 is linked to diabetic kidney disease.